December 2016 FDA Recall Fluconazole by Baxter Healthcare Corporation
D-0206-2017 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Baxter Healthcare Corporation on December 6, 2016 for the product Fluconazole. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed in United States, United Arab Emirates, and Colombia and the recall is currently terminated.

Recall Number: D-0206-2017

Reason for Recall
Lack of Assurance of Sterility: confirmed customer complaints of leaking bags.
Initiated
12-06-2016
Reported
12-28-2016
Quantity
30,910 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Baxter Healthcare Corporation
United States, United Arab Emirates, and Colombia
Fluconazole Injection, USP, 200 mg/100 mL (2mg/mL), 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1446, NDC 0338-6046-48.

Batch or Lot Expiration Information

Lot# : P344028 on bags, P344028A on shipping container, Exp 12/31/2017

Affected Packages Involved in this Recall